Amalgamated Bank’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $23.7M | Sell |
47,716
-5,553
| -10% | -$2.46M | 0.16% | 85 |
|
|
2026
Q1 | $23.8M | Sell |
53,269
-1,851
| -3% | -$863K | 0.18% | 83 |
|
|
2025
Q4 | $25M | Sell |
55,120
-1,394
| -2% | -$601K | 0.18% | 87 |
|
|
2025
Q3 | $22.1M | Buy |
56,514
+779
| +1% | +$326K | 0.16% | 99 |
|
|
2025
Q2 | $24.8M | Buy |
55,735
+2,005
| +4% | +$924K | 0.19% | 87 |
|
|
2025
Q1 | $26M | Buy |
53,730
+726
| +1% | +$338K | 0.22% | 79 |
|
|
2024
Q4 | $21.3M | Sell |
53,004
-3,186
| -6% | -$1.48M | 0.18% | 88 |
|
|
2024
Q3 | $26.1M | Buy |
56,190
+2,383
| +4% | +$1.14M | 0.22% | 71 |
|
|
2024
Q2 | $25.2M | Sell |
53,807
-1,801
| -3% | -$782K | 0.21% | 75 |
|
|
2024
Q1 | $23.2M | Sell |
55,608
-8,932
| -14% | -$3.78M | 0.2% | 82 |
|
|
2023
Q4 | $26.3M | Sell |
64,540
-3,649
| -5% | -$1.35M | 0.21% | 81 |
|
|
2023
Q3 | $23.7M | Sell |
68,189
-8,261
| -11% | -$2.89M | 0.2% | 84 |
|
|
2023
Q2 | $26.9M | Sell |
76,450
-4,647
| -6% | -$1.57M | 0.22% | 82 |
|
|
2023
Q1 | $25.6M | Buy |
81,097
+11,188
| +16% | +$3.36M | 0.22% | 85 |
|
|
2022
Q4 | $20.2M | Sell |
69,909
-5,767
| -8% | -$1.76M | 0.18% | 101 |
|
|
2022
Q3 | $21.9M | Buy |
75,676
+6,579
| +10% | +$1.89M | 0.21% | 78 |
|
|
2022
Q2 | $19.5M | Sell |
69,097
-292
| -0.4% | -$78.2K | 0.18% | 92 |
|
|
2022
Q1 | $18.1M | Sell |
69,389
-1,785
| -3% | -$424K | 0.14% | 116 |
|
|
2021
Q4 | $15.6M | Buy |
71,174
+5,885
| +9% | +$1.14M | 0.12% | 140 |
|
|
2021
Q3 | $11.8M | Sell |
65,289
-2,652
| -4% | -$518K | 0.1% | 162 |
|
|
2021
Q2 | $13.7M | Buy |
67,941
+51,971
| +325% | +$10.9M | 0.11% | 149 |
|
|
2021
Q1 | $3.43M | Sell |
15,970
-762
| -5% | -$167K | 0.13% | 129 |
|
|
2020
Q4 | $3.95M | Sell |
16,732
-93
| -0.6% | -$21.3K | 0.15% | 107 |
|
|
2020
Q3 | $4.58M | Sell |
16,825
-497
| -3% | -$137K | 0.2% | 79 |
|
|
2020
Q2 | $5.03M | Sell |
17,322
-26,032
| -60% | -$7.06M | 0.23% | 70 |
|
|
2020
Q1 | $10.3M | Sell |
43,354
-1,051
| -2% | -$241K | 0.25% | 75 |
|
|
2019
Q4 | $9.72M | Buy |
44,405
+1,776
| +4% | +$359K | 0.18% | 105 |
|
|
2019
Q3 | $7.22M | Buy |
42,629
+8,614
| +25% | +$1.52M | 0.15% | 126 |
|
|
2019
Q2 | $6.24M | Sell |
34,015
-4,339
| -11% | -$759K | 0.15% | 130 |
|
|
2019
Q1 | $7.05M | Buy |
38,354
+815
| +2% | +$151K | 0.17% | 108 |
|
|
2018
Q4 | $6.22M | Sell |
37,539
-1,024
| -3% | -$177K | 0.18% | 105 |
|
|
2018
Q3 | $7.43M | Sell |
38,563
-1,209
| -3% | -$215K | 0.18% | 107 |
|
|
2018
Q2 | $6.76M | Buy |
39,772
+2,880
| +8% | +$446K | 0.17% | 114 |
|
|
2018
Q1 | $6.01M | Buy |
36,892
+3,623
| +11% | +$592K | 0.16% | 121 |
|
|
2017
Q4 | $4.99M | Buy |
33,269
+2,921
| +10% | +$433K | 0.13% | 140 |
|
|
2017
Q3 | $4.61M | Buy |
30,348
+1,082
| +4% | +$163K | 0.14% | 137 |
|
|
2017
Q2 | $3.77M | Buy |
29,266
+10,589
| +57% | +$1.27M | 0.12% | 158 |
|
|
2017
Q1 | $2.04M | Sell |
18,677
-8,020
| -30% | -$706K | 0.1% | 183 |
|
|
2016
Q4 | $1.97M | Buy |
26,697
+4,651
| +21% | +$378K | 0.09% | 208 |
|
|
2016
Q3 | $1.92M | Buy |
22,046
+54
| +0.2% | +$5.1K | 0.11% | 168 |
|
|
2016
Q2 | $2.23M | Buy |
21,992
+12,289
| +127% | +$1.06M | 0.13% | 141 |
|
|
2016
Q1 | $771K | Buy |
9,703
+2,313
| +31% | +$209K | 0.08% | 311 |
|
|
2015
Q4 | $930K | Sell |
7,390
-1,870
| -20% | -$226K | 0.11% | 172 |
|
|
2015
Q3 | $964K | Buy |
9,260
+345
| +4% | +$44.3K | 0.1% | 187 |
|
|
2015
Q2 | $1.1M | Buy |
8,915
+630
| +8% | +$79.4K | 0.11% | 156 |
|
|
2015
Q1 | $977K | Buy |
8,285
+1,938
| +31% | +$232K | 0.12% | 188 |
|
|
2014
Q4 | $754K | Sell |
6,347
-928
| -13% | -$105K | 0.12% | 200 |
|
|
2014
Q3 | $817K | Buy |
7,275
+459
| +7% | +$43.7K | 0.12% | 178 |
|
|
2014
Q2 | $645K | Buy |
6,816
+865
| +15% | +$60.7K | 0.1% | 241 |
|
|
2014
Q1 | $421K | Sell |
5,951
-113
| -2% | -$8.95K | 0.07% | 389 |
|
|
2013
Q4 | $451K | Buy |
+6,064
| New | +$422K | 0.08% | 359 |
|
Other funds holding VRTX
Amalgamated Bank's VRTX Position: Q2 2026 in Review
Amalgamated Bank reduced its Vertex Pharmaceuticals (VRTX) stake by 10% in Q2 2026, selling an estimated $2.46M and leaving 47,716 shares worth $23.7M. The position accounts for 0.16% of the portfolio, ranked #85.
Amalgamated Bank first reported a position in VRTX in Q4 2013 and has held it in 51 quarters since. The position peaked at $26.9M in Q2 2023. 1,014 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Amalgamated Bank held 47,716 shares of Vertex Pharmaceuticals worth $23.7M as of Q2 2026.
- Amalgamated Bank sold 5,553 Vertex Pharmaceuticals shares in Q2 2026, an estimated $2.46M.
- Vertex Pharmaceuticals made up 0.16% of Amalgamated Bank's portfolio in Q2 2026, its #85 holding.
- Amalgamated Bank first reported a position in Vertex Pharmaceuticals in Q4 2013 and has held it in 51 quarters since.
- Amalgamated Bank's Vertex Pharmaceuticals position peaked at $26.9M in Q2 2023.
- 1,014 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.